The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale
about
Chemotherapy-induced peripheral neurotoxicity: a critical analysisLong- and short-term health effects of pesticide exposure: a cohort study from ChinaCentral pain processing in chronic chemotherapy-induced peripheral neuropathy: a functional magnetic resonance imaging study[EXPRESS] Ion channels and neuronal hyperexcitability in chemotherapy-induced peripheral neuropathy; cause and effect?Paclitaxel-induced neuropathy: potential association of MAPT and GSK3B genotypesA pilot study of acupuncture in treating bortezomib-induced peripheral neuropathy in patients with multiple myeloma.The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings.Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin.Limb Hypothermia for Preventing Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer Patients: A Pilot StudyPeripheral neuropathy during bortezomib treatment of multiple myeloma: a review of recent studies.Guidelines for supportive care in multiple myeloma 2011.Chemotherapy-induced peripheral neuropathy: prevention and treatment.Chemotherapy-induced polyneuropathy: major agents and assessment by questionnaires.Factors associated with the development and severity of oxaliplatin-induced peripheral neuropathy: a systematic review.Optimal clinical assessment strategies for chemotherapy-induced peripheral neuropathy (CIPN): a systematic review and Delphi survey.Vincristine-induced peripheral neuropathy in survivors of childhood acute lymphoblastic leukaemia.Early, progressive, and sustained dysfunction of sensory axons underlies paclitaxel-induced neuropathy.Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy.Comparison of two chemotherapy-induced peripheral neuropathy measurement approaches in children.Vincristine-induced neuropathy in childhood ALL (acute lymphoblastic leukemia) survivors: prevalence and electrophysiological characteristics.Corneal confocal microscopy in patients with oxaliplatin-induced peripheral neuropathy.Taxane-Induced Peripheral Neurotoxicity.CYP3A5 genotype and its impact on vincristine pharmacokinetics and development of neuropathy in Kenyan children with cancer.Lenalidomide in patients with chemotherapy-induced polyneuropathy and relapsed or refractory multiple myeloma: results from a single-centre prospective study.Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial.Pharmacotherapy options for managing chemotherapy-induced peripheral neurotoxicity.Characterization of the peripheral neuropathy associated with brentuximab vedotin treatment of Mycosis Fungoides and Sézary Syndrome.Pain in Platin-Induced Neuropathies: A Systematic Review and Meta-Analysis.Electroclinical biomarkers of early peripheral neurotoxicity from oxaliplatin.Serum micronutrients and prealbumin during development and recovery of chemotherapy-induced peripheral neuropathy.Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients.Advanced age and liability to oxaliplatin-induced peripheral neuropathy: post hoc analysis of a prospective study.Peripheral neurotoxicity of oxaliplatin in combination with 5-fluorouracil (FOLFOX) or capecitabine (XELOX): a prospective evaluation of 150 colorectal cancer patients.Impact of oxaliplatin-induced neuropathy: a patient perspective.Chemotherapy-induced peripheral neurotoxicity can be misdiagnosed by the National Cancer Institute Common Toxicity scale.Neuropathic pain and chemotherapy-induced peripheral neurotoxicity: the issue.Characterization and diagnostic evaluation of chronic polyneuropathies induced by oxaliplatin and docetaxel comparing skin biopsy to quantitative sensory testing and nerve conduction studiesLong-term course of oxaliplatin-induced polyneuropathy: a prospective 2-year follow-up studyUltrasound assessment of oxaliplatin-induced neuropathy and correlations with neurophysiologic findingsChemotherapy-Induced Neuropathy
P2860
Q27010318-32AF389A-C142-4491-B9A2-0D3B189D101CQ28395682-3F2360EF-421B-4882-ADEF-E45E5E16D9ABQ33599361-43AB6170-0055-41C3-8842-344BAFFDA50FQ33824948-28B003E3-61D5-4E1A-8E9C-0E3F1AFB7069Q35191233-B728F6BA-61C9-43BC-ABFF-9182F7D4B859Q36037229-D9105D8D-0941-461B-BBD9-BA0E413E686BQ36551631-4B465076-C413-4462-AC8D-C5BC7DB592A7Q37404101-C45C152F-EC7E-468F-BBA4-E91783342551Q37574855-48FC5596-A67F-423A-870B-E5481FB6A4E2Q37760210-454397D3-CD4D-4AC3-B61A-171566A087F8Q37868637-1E271CC7-8F1A-47E6-8F41-B6D13A7984C8Q37911252-A0D2280D-31D7-4966-8CCE-97CC67D4F6CAQ38209390-F0D24F4E-A3C2-402B-A3E6-556F992BE340Q38707400-D542A9EA-EDCA-418F-B8D2-BC8EC20E210DQ39356105-C05552BB-5688-40AC-801D-30A6D62A2832Q40358186-D6BE8033-02A4-47E1-BF21-FEE41508E715Q42750577-15ABF9AA-34B8-4D0D-B894-7E39E623AF8BQ43278321-151BE632-3A87-4E0E-92A3-81D9B514BCECQ43495818-BF077C03-4990-42C6-968D-D90C20EF369DQ44301929-791257B8-54FB-499E-9DF1-C07211350020Q44718187-2C8D0BAF-0C50-4463-B25D-FB372F569EE6Q45759415-E474E38C-F932-456D-99EC-85374E3FB076Q46455283-A7DAD3B5-B7E2-4AA9-9CB5-3733B8FA53B3Q46501555-511EBA8E-8A94-490C-AFDB-422EEB320FD0Q47266458-1D4D575E-0BD5-44C6-928D-E1F977244B9DQ47344383-B8AD2395-6FCA-46B8-BB85-01020D48C5DDQ47423347-20614795-8B07-4777-9204-8192752CED10Q48192466-DFED0A43-3516-455F-9A43-7F0DF467228AQ49169362-6341B6AC-5F52-4EE7-B6C9-307DC52AA9CDQ50237975-339C729B-C8BE-4196-ABB0-F18387FEBA57Q50797877-560E9603-A935-4098-94C7-61F5EB2B9E8FQ50887433-1D79DBD6-19A3-4B6D-B485-87CE512661CEQ50922149-EF1AD173-C763-4DDB-A203-9C9052A04AFBQ50956973-4875B470-164A-4469-8B2E-F79FA3B996A7Q51000217-AE72DD66-71E4-4C75-AD79-A630EFFDAE92Q54283638-E7B8E8E3-63B5-4947-BA57-9355F72CDE4BQ58455979-1FAADBF2-DC0F-4977-8831-0E18DC023A4FQ58874339-5624827C-A7FC-4578-B7C8-1C2529C1F6B2Q58874362-E0E17F79-451D-42FD-8A16-77788B4D5083Q58874394-BD1D830E-7B56-4982-937A-DF34A11D26C1
P2860
The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale
description
article
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2007
@uk
name
The Total Neuropathy Score as ...... nstitute-Common Toxicity Scale
@en
The Total Neuropathy Score as ...... nstitute-Common Toxicity Scale
@nl
type
label
The Total Neuropathy Score as ...... nstitute-Common Toxicity Scale
@en
The Total Neuropathy Score as ...... nstitute-Common Toxicity Scale
@nl
prefLabel
The Total Neuropathy Score as ...... nstitute-Common Toxicity Scale
@en
The Total Neuropathy Score as ...... nstitute-Common Toxicity Scale
@nl
P2093
P50
P1476
The Total Neuropathy Score as ...... nstitute-Common Toxicity Scale
@en
P2093
Andrea Lissoni
Barbara Frigeni
Chiara Briani
Claudio Zanna
Francesca Lanzani
Francesca Pastorelli
Gabriella Zara
Italian NETox Group
Mariagrazia Manicone
Marialuisa Piatti
P2860
P304
P356
10.1111/J.1529-8027.2007.00141.X
P577
2007-09-01T00:00:00Z